Multiple sclerosis is one step closer to being cured. British scientists have discovered 29 new genetic variants linked to multiple sclerosis (MS) and it’s thought that these findings could help pharmaceutical companies focus treatment research on exact areas of the immune system.
This new breakthrough purports that T-cells — a type of white blood cell responsible for mounting an immune response — and chemicals called interleukins play a major role in the development of MS.
This exciting news comes on the heels of earlier findings that vitamin D via sunshine may help curb what is known as first demyelinating events, or FDE. First demyelinating events are warning signs of development of multiple sclerosis (MS). Multiple sclerosis may have an enemy in vitamin D (the sunshine vitamin). The sun may be giving you more than just a nice tan. The recent study suggests that exposure to sunlight may reduce your risk of developing multiple sclerosis. Multiple sclerosis, a severely debilitating nerve disease, is less common in the tropics and scientists assumed that this may be attributable to sun exposure and vitamin D levels. In MS, the fatty myelin sheaths that insulate nerves in the central nervous system are damaged by the immune system. Vitamin D, a nutrient that the body produces from sunlight, is noted to likely have a positive impact on the immune system and therefore may help protect against the autoimmune disease. While there have been studies linking vitamin D to incidence of MS, none of these studies linked the quantity of sun exposure to the risk of developing MS.